Market Tracker

10/20 5:16pm ET

Trovagene Inc (NASDAQ:TROV)

0.805
Delayed Data
As of Oct 20
 -0.0042 / -0.52%
Today’s Change
0.61
Today|||52-Week Range
4.30
-61.67%
Year-to-Date
No recent news for Trovagene Inc.

Today’s Trading

Previous close0.81
Today’s open0.81
Day’s range0.80 - 0.83
Volume350,491
Average volume (3 months)865,046
Market cap$30.2M
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-13.22%
Earnings growth (this year)+37.23%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+21.82%
P/E ratioNM
Price/Sales166.87
Price/Book1.26

Competitors

 Today’s
change
Today’s
% change
MBOTMicrobot Medical Inc+0.02+1.71%
ONCSOncoSec Medical Inc-0.04-3.02%
PTIProteostasis Therape...+0.14+6.67%
--BARD1 Life Sciences ...0.000.00%
Data as of 3:59pm ET, 10/20/2017

Financials

Next reporting dateNovember 15, 2017
EPS forecast (this quarter)-$0.14
Annual revenue (last year)$381.1K
Annual profit (last year)-$39.2M
Net profit margin-10,287.75%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Bill Welch
Chief Scientific Officer
Mark Erlander
Corporate headquarters
San Diego, California

Forecasts